Sunij Pharma Private Limited, a active private limited company, was established on 28 September 2000 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2000PTC038712. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.48 Cr.
It upholds a compliant status. Employing 33 professional, Its leadership includes Falguni Niraj Katwala (Managing Director), Mita Parikh Vallabh (Director), Dipti Tusharbhai Soparkar (Director). Past directors included Falguni Niraj Katwala, Niraj Umakant Katwala, Narendra Chandulal Dalal. It holds no open charges and ₹3.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at T1/B National Parkgulbai Tekra, Ahmedabad, Gujarat, 380015.
U24231GJ2000PTC038712
038712
28 September 2000
₹3.00 Cr
₹1.48 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sunij Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Falguni Niraj Katwala | Managing Director | 01 Apr 2010 | Current |
| Mita Parikh Vallabh | Director | 17 Mar 2017 | Current |
| Dipti Tusharbhai Soparkar | Director | 17 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 17 Mar 2017 | Past |
| Pramod Abcsdd | Managing Director | 01 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 07 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sunij Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.7% increase. The company also saw a substantial improvement in profitability, with a 89.44% increase in profit. The company's net worth moved up by a moderate rise of 2.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sunij Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2012 | The Social Co-Operative Bank Limited | ₹1.00 M | Satisfied |
| 23 Jan 2002 | Social Co-Op Bank Ltd | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Sunij Pharma has a workforce of 33 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sunij Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunij Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sunij Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Sunij Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge registered on 21 May 2012 via Charge ID 10361723 with The Social Co-Operative Bank Limited was fully satisfied on 06 Apr 2017. was recorded as a recent event.
The activity Mita Parikh Vallabh was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 9 months . was completed.
Progress on Dipti Tusharbhai Soparkar was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 9 months . was documented.
The activity A charge with The Social Co-Operative Bank Limited amounted to Rs. 0.10 Cr with Charge ID 10361723 was registered on 21 May 2012. was completed.
The CIN of Sunij Pharma Private Limited is U24231GJ2000PTC038712.
Sunij Pharma Private Limited is headquartered at T1/B National Parkgulbai Tekra, Ahmedabad, Gujarat, 380015.
Sunij Pharma Private Limited was incorporated on 28 September 2000.
The current directors of Sunij Pharma Private Limited are
The primary industry of Sunij Pharma Private Limited is Manufacturing.
Sunij Pharma Private Limited is unlisted.
The authorized capital of Sunij Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.48 Cr.
The compliance status of Sunij Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX